Moderna Inc., developer of a currently authorized Covid-19 vaccine, is expanding its vaccine pipeline to cover three more common infectious viral diseases. . . . → Read More: Moderna Developing Flu, HIV, Nipah Vaccines
|
|||||
|
       
  |
 Comments are closed  New products  biomedical, biotechnology, genomics, life sciences, NIH, pharmaceuticals 
A start-up biotechnology company that aims to bring drugs to market at lower cost is raising $500 million in its second venture funding round. . . . → Read More: Drug Price Disruptor Biotech Raises $500M in New Funds Comments are closed Finance biomedical, biotechnology, cancer, clinical trials, economics, entrepreneurs, equity, investment, licensing, life sciences, pharmaceuticals, venture capital 
A current Covid-19 vaccine is shown in lab tests to produce antibodies that appear to protect against new mutations found in South Africa and the U.K. . . . → Read More: Vaccine Shown Active Against New Covid-19 Variants One comment - (Comments are closed) New products biomedical, biotechnology, Covid-19, Europe, FDA, genomics, life sciences, pharmaceuticals, preclinical, university 
Vaccine developer CureVac and global drug maker Bayer are partnering on further development, authorization, and supply of CureVac’s Covid-19 vaccine. . . . → Read More: CureVac, Bayer Partner on Covid-19 Vaccine Supply One comment - (Comments are closed) Joint ventures/collaborations biomedical, biotechnology, clinical trials, Covid-19, Europe, genomics, life sciences, manufacturing, pharmaceuticals 
A company developing cellular and genetic therapies for cancer designed like electronic circuits is raising $105 million in its second venture round. . . . → Read More: Synthetic Biology Company Raises $105M in New Funds One comment - (Comments are closed) Finance biomedical, biotechnology, cancer, engineering, entrepreneurs, equity, Europe, genomics, investment, life sciences, pharmaceuticals, venture capital 
A new biotechnology enterprise is underway that develops synthetic viruses attacking solid tumor cancers, based on research at the Salk Institute. . . . → Read More: Synthetic Virus Company Forms, Raises $77M 2 comments - (Comments are closed) Finance, New products biomedical, biotechnology, cancer, entrepreneurs, equity, investment, life sciences, pharmaceuticals, preclinical, venture capital 
The U.S. Food and Drug Administration issued draft administrative and procedural guidelines for genetic disorders treated with precise gene therapies. . . . → Read More: FDA Issues Precision Genomic Drug Guidance Comments are closed Regulations biomedical, biotechnology, clinical trials, FDA, genomics, life sciences, pharmaceuticals, preclinical, university 
A start-up biotech company says it received clearance from the Food and Drug Administration to begin a clinical trial of its gene therapy for Krabbe disease. . . . → Read More: Trial OKed for Rare Disease Gene Therapy Comments are closed New products, Regulations biomedical, biotechnology, clinical trials, entrepreneurs, FDA, genomics, life sciences, manufacturing, pharmaceuticals, stem cells, university 
Historians will record 2020 as a pivotal and dangerous time, and our corner of that world at the intersection of science and business played a visible role in it. . . . → Read More: A Look Back at 2020 on Science & Enterprise 
A biotechnology vaccine developer began enrolling participants in a large-scale clinical trial testing a vaccine to prevent Covid-19 infections. . . . → Read More: Large Covid-19 Vaccine Trial Underway in U.S. One comment - (Comments are closed) New products biomedical, biotechnology, clinical trials, Covid-19, life sciences, pharmaceuticals |
||||
|
Copyright © 2021 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||